Radical Prostatectomy clinical trials

Explore recruiting radical prostatectomy clinical trials.

Recruiting radical prostatectomy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Radical Prostatectomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Advanced Prostate Cancer who are Candidates for Radical Prostatectomy (LUPUS)

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Short versus long-term androgen deprivation therapy combined with salvage radiotherapy in prostate cancer patients with biochemical recurrence after prostatectomy: a multicentre phase III randomised controlled trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prostate Androgen Response Investigation using a Stratification BIOmarker - PARIS-BIO Predicting prostate cancer downstageing by neoadjuvant Darolutamide with PCAI ImmunoScore in a non-randomised open label prospective trial.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of peri-operative tEstosterone levels oN Functional and oncological Outcomes following RadiCal prostatEctomy (ENFORCE)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open label, single-arm, phase 2 study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in high-risk prostate cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

GETUG 20 : Phase III randomised trial to evaluate the benefit of adjuvant hormonal treatment with leuprorelin acetate (Eligard® 45 mg) for 24 months after radical prostatectomy in patients with high risk of recurrence

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Radical Prostatectomy trials by city

Radical Prostatectomy in Toronto Radical Prostatectomy in Vancouver Radical Prostatectomy in Montreal Radical Prostatectomy in Calgary Radical Prostatectomy in Edmonton Radical Prostatectomy in Ottawa Radical Prostatectomy in Winnipeg Radical Prostatectomy in Quebec City Radical Prostatectomy in Hamilton Radical Prostatectomy in Kitchener Radical Prostatectomy in London Radical Prostatectomy in Halifax Radical Prostatectomy in New York Radical Prostatectomy in Los Angeles Radical Prostatectomy in Chicago Radical Prostatectomy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease